GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Four-Pronged attack on stomach cancer tested before surgery
Disease control Not yet recruitingThis study is testing a combination of two immunotherapy drugs, one targeted therapy drug, and a standard chemotherapy regimen. The goal is to see if this four-drug combination can shrink tumors enough to allow for surgical removal in patients with a specific type of advanced sto…
Matched conditions: GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New stomach cancer treatment aims to shrink tumors before surgery
Disease control Not yet recruitingThis study is testing if a combination of chemotherapy, low-dose radiation, and an immunotherapy drug (tislelizumab) given before and after surgery works better than chemotherapy alone for people with a certain type of advanced stomach cancer. The goal is to see if the new combin…
Matched conditions: GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Two-Pronged attack on advanced stomach cancer enters testing
Disease control Not yet recruitingThis study is testing a new combination treatment for people with advanced stomach or gastroesophageal junction (GEJ) cancer that is HER2-negative. It combines an immunotherapy drug (QL1706) with a modified chemotherapy regimen (TFOX) as the first treatment for the cancer. The ma…
Matched conditions: GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC